Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103695854 | 10369585 | 4 | F | 20160223 | 20140807 | 20160922 | PER | US-AMGEN-USASP2014023812 | AMGEN | 65.00 | YR | E | F | Y | 0.00000 | 20160922 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103695854 | 10369585 | 1 | PS | filgrastim | FILGRASTIM | 1 | Unknown | UNK | U | 103353 | UNKNOWN FORMULATION | ||||||||
| 103695854 | 10369585 | 2 | SS | pegfilgrastim | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNK | U | 0 | 6 | MG | UNKNOWN FORMULATION | ||||||
| 103695854 | 10369585 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 1000 MG, UNK | 0 | 1000 | MG | ||||||||
| 103695854 | 10369585 | 4 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 726 MG, UNK | 0 | 726 | MG | ||||||||
| 103695854 | 10369585 | 5 | C | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 900 MG, UNK | 0 | 900 | MG | ||||||||
| 103695854 | 10369585 | 6 | C | TAXOTERE | DOCETAXEL | 1 | Intravenous (not otherwise specified) | 170 MG, UNK | 0 | 170 | MG | ||||||||
| 103695854 | 10369585 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 103695854 | 10369585 | 8 | C | ATIVAN | LORAZEPAM | 1 | Intravenous (not otherwise specified) | 0.5 MG, UNK | 0 | .5 | MG | ||||||||
| 103695854 | 10369585 | 9 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 25 MG, UNK | 0 | 25 | MG | ||||||||
| 103695854 | 10369585 | 10 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 10 ML, UNK | 0 | 10 | ML | ||||||||
| 103695854 | 10369585 | 11 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 250 ML, UNK | 0 | 250 | ML | ||||||||
| 103695854 | 10369585 | 12 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0.25 MG, UNK | 0 | .25 | MG | ||||||||
| 103695854 | 10369585 | 13 | C | EMEND | APREPITANT | 1 | Intravenous (not otherwise specified) | 150 MG, UNK | 0 | 150 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103695854 | 10369585 | 1 | Product used for unknown indication |
| 103695854 | 10369585 | 2 | Product used for unknown indication |
| 103695854 | 10369585 | 3 | Breast cancer |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103695854 | 10369585 | Injection site reaction | |
| 103695854 | 10369585 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103695854 | 10369585 | 2 | 20121219 | 0 | ||
| 103695854 | 10369585 | 3 | 20121218 | 0 | ||
| 103695854 | 10369585 | 4 | 20130108 | 0 | ||
| 103695854 | 10369585 | 5 | 20130108 | 0 | ||
| 103695854 | 10369585 | 6 | 20130108 | 0 | ||
| 103695854 | 10369585 | 7 | 20130108 | 0 | ||
| 103695854 | 10369585 | 8 | 20130108 | 0 | ||
| 103695854 | 10369585 | 9 | 20130108 | 0 |